SPENCER WALLACE: Open Payments
NPI 1831713387 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 44 payments from 12 companies in 2025. Trend: 2023 $782 · 2024 $833 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 24 | $477 |
| Janssen Biotech, Inc. | 5 | $92 |
| Astellas Pharma US Inc | 3 | $52 |
| Endo USA, Inc. | 2 | $46 |
| Medtronic, Inc. | 1 | $44 |
| Olympus America Inc. | 2 | $41 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $37 |
| Blue Earth Diagnostics | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| UROGEN PHARMA, INC. | 1 | $19 |
Products named: GEMTESA, ERLEADA, XTANDI, ORGOVYX, XIAFLEX, INTERSTIM, iTIND System, PYLARIFY.
Industry payments across AL — which companies pay providers there.
